期刊文献+

血清胱抑素C、β_(2^-)微球蛋白及肌酐在多发性骨髓瘤诊断中的价值 被引量:13

Value of serum cystatin C, β_(2^-) microglobulin and creatinine in the diagnosis of multiple myeloma
下载PDF
导出
摘要 目的探讨血清胱抑素C(cystatin C,Cys-C)、β2-微球蛋白(β2-microglobulin,β2-MG)及肌酐(creatinine,Cr)在多发性骨髓瘤(multiple myeloma,MM)中的诊断意义。方法使用日立7600全自动生化分析仪检测2010年2月-2014年1月海南农垦那大医院及南方医院住院的43例初诊MM患者和30例健康体检者血清Cys-C、β2-MG、Cr、尿酸(uric acid,UA)及尿素的水平。应用受试工作特征曲线(receiver operating characteristic curve,ROC)评价Cys-C、β2-MG和Cr在MM诊断中的价值。结果 MM患者Cys-C水平(2.06±0.82)mg/L明显高于健康对照组(0.71±0.18)mg/L(P<0.01);并且与β2-MG呈明显正相关(r=0.523,P<0.05)。Durie-Salmon分期中,Ⅲ期Cys C水平(3.14±1.38)mg/L明显高于Ⅱ期(1.35±0.16)mg/L和Ⅰ期(0.97±0.18)mg/L(P<0.01);Ⅲ期与Ⅰ期、Ⅱ期血清Cr和β2-MG水平比较差异有统计学意义(P<0.05)。不同免疫分型中,轻链型血清Cys-C水平(2.75±1.01)mg/L明显高于不分泌型(1.49±0.53)mg/L(P<0.05);Ig A型血清β2-MG水平(7.48±4.52)mg/L明显高于不分泌型(5.37±2.64)mg/L(P<0.05)。ROC分析显示,Cys C的曲线下的面积(area under curve,AUC)及其95%置信区间(0.912,95%CI:0.891~0.960)高于β2-MG(0.853,95%CI:0.821~0.894)和Cr(0.741,95%CI:0.702~0.795),差异有统计学意义(P<0.05)。结论 Cys-C可以作为诊断MM患者肾功能早期损害的指标之一,且优于β2-MG和Cr,对临床分期、肿瘤负荷及判断预后有一定的帮助。 Objective To investigate the diagnosis significance of serum cystatin C (Cys-C),β2-microglobulin (β2-MG) and creatinine (Cr) in multiple myeloma (MM).Methods The serum levels of Cys-C,β2-MG,Cr,uric acid (UA) and urea of 43 newly diagnosed MM patients and 30 healthy persons in Hainan Nongken Nada Hospital and Nanfang Hospital from February 2010 to January 2014 were detected using Hitachi 7600 automatic biochemical analyzer.Receiver operating characteristic curve (ROC) was used to evaluate the value of Cys-C,β2-MG and Cr in the diagnosis of MM.Results The level of Cys-C in patients with MM (2.06 ± 0.82) mg/L was significantly higher than in the control group (0.71 ± 0.18) mg/L (P < 0.01),and it was significant positive correlated with β2-MG (r=0.523,P < 0.05).During Durie-Salmon stage,the level of CysC (3.14 ± 1.38) mg/L in phase Ⅲ was significantly higher than that in phase Ⅱ (1.35 ± 0.16) mg/L and phase Ⅰ (0.97 ± 0.18) mg/L (P < 0.01).The levels of serum Cr and β2-MG in phase Ⅲ showed statistically significant difference comparing with that in phase Ⅰ and Ⅱ (P < 0.05).Cys-C level of serum light chain (2.75 ± 1.01) mg/L was significantly higher than that of no secretion (1.49 ± 0.53) mg/L in different immune classification (P < 0.05),and β2-MG level of IgA type serum (7.48 ± 4.52) mg/L was significantly higher than that of no secretion (5.37 ± 2.64) mg/L (P < 0.05).Receiver operating characteristic curve analysis showed that area under curve (AUC) and 95% confidence interval of CysC (0.912,95%CI:0.891-0.960) were higher than that of the β2-MG (0.853,95%CI:0.821-0.894) and Cr (0.741,95%CI:0.702-0.795),the difference was statistically significant (P < 0.05).Conclusion Cys-C can be used as one of indexes for the early diagnosis of MM patients with renal damage,which is better than β2-MG and Cr,and it also can help with clinical stage,tumor burden and prognosis.
出处 《解放军医学院学报》 CAS 2014年第11期1126-1129,共4页 Academic Journal of Chinese PLA Medical School
关键词 血清胱抑素C Β2-微球蛋白 多发性骨髓瘤 cystatin C β2-microglobulin multiple myeloma
  • 相关文献

参考文献7

二级参考文献36

共引文献120

同被引文献120

  • 1王瑞石,刘志红,尹茹,陈朝红,黎磊石.肾小管损伤标记物检测的临床意义及其影响因素[J].肾脏病与透析肾移植杂志,2005,14(2):110-116. 被引量:46
  • 2邱录贵.多发性骨髓瘤的发病与国人特点[J].中国实用内科杂志:临床前沿版,2006,26(6):886-888. 被引量:52
  • 3程石,宋茂民,史敬东.核因子κB活化对急性坏死性胰腺炎肺泡巨噬细胞炎症介质表达的影响及意义[J].中华肝胆外科杂志,2006,12(11):764-766. 被引量:11
  • 4陈楠.多发性骨髓瘤肾脏损害诊断和治疗[J].内科理论与实践,2007,2(6):373-375. 被引量:8
  • 5Keppler D. Towards novel anti-cancer strategies based on cystatinfunction [ J ] . Cancer Lett, 2006, 235 ( 2) : 159-176.
  • 6Turk V,Brzin J, Kotnik M, et al. Human cysteine proteinasesand their protein inhibitors stefins, cystatins and kininogens [ J ].Biomed Biochim Acta, 1986, 45 ( 11/12 ) : 1375-1384.
  • 7Shannon P, Pennacchio LA, Houseweart MK, et al.Neuropathological changes in a mouse model of progressive myoclonusepilepsy : cystatin B deficiency and Unverricht-Lundborg disease[ J ].J Neuropathol Exp Neurol, 2002, 61 ( 12) : 1085-1091.
  • 8Turk B, Krizaj I,Kralj B, et al. Bovine stefin C, a new member ofthe stefin family [ J ] . J Biol Chem, 1993,268 (10) : 7323-7329.
  • 9Kos J,Lah TT. Cysteine proteinases and their endogenous inhibitors :target proteins for prognosis,diagnosis and therapy in cancer ( review )[J] .Oncol Rep, 1998,5(6): 1349-1361.
  • 10Ritonja A, Machleidt W, Barrett AJ. Amino acid sequence of theintracellular cysteine proteinase inhibitor cystatin B from human liver[J ] . Biochem Biophys Res Commun, 1985, 131 (3): 1187-1192.

引证文献13

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部